Going with the flow: from circulating tumor cells to DNA. (Q43826044)

27 November 2017

Going with the flow: from circulating tumor cells to DNA. (English)

1 reference

27 November 2017

François-Clément Bidard

series ordinal

1

object named as

Francois-Clement Bidard

0 references

Jorge Reis-Filho

series ordinal

3

object named as

Jorge S Reis-Filho

1 reference

27 November 2017

2

Britta Weigelt

1 reference

PubMed ID

24132635

27 November 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

Science Translational Medicine

27 November 2017

1 reference

27 November 2017

5

1 reference

27 November 2017

207

1 reference

27 November 2017

207ps14

1 reference

Lessons from the cancer genome

27 November 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Tumour evolution inferred by single-cell sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

The life history of 21 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Tumour heterogeneity in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

The causes and consequences of genetic heterogeneity in cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Analysis of circulating tumor DNA to monitor metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Circulating tumor cells: liquid biopsy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Circulating tumor cells: approaches to isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Detection and quantification of mutations in the plasma of patients with colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Development of personalized tumor biomarkers using massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Detection and quantification of rare mutations with massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Detection of ultra-rare mutations by next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Cell-free nucleic acids as biomarkers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Recent translational research: circulating tumor cells in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Biomarkers characterization of circulating tumour cells in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

The implications of clonal genome evolution for cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Noninvasive detection of HER2 amplification with plasma DNA digital PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

Selection and adaptation during metastatic cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006305

10.1126/SCITRANSLMED.3006305

21 January 2018

Identifiers

DOI

1 reference

release_pmd5ruyxgzfopjmym3tzsfcybu

27 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pmd5ruyxgzfopjmym3tzsfcybu

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

24132635

1 reference

PubMed ID

24132635